Our CMA service is designed to identify clinically relevant microdeletions/duplications and CNVs, making it a valuable tool for detecting chromosomal abnormalities in patients.

CMA helps to identify diseases in approximately 15-20% of individuals with unexplained developmental delay, autism spectrum disorder and multiple congenital anomalies

We believe our CMA service can provide you with valuable and accurate genetic insights.